Stories about: Theranos

News Notes: Headlines in science and innovation

An occasional roundup of news items Vector finds noteworthy.

Zika’s surface in stunning detail; mosquito tactics

Zika virus
(Purdue University image/courtesy of Kuhn and Rossmann research groups)

We haven’t curbed the Zika epidemic yet. But cryo-electron microscopy — a newer, faster alternative to X-ray crystallography — at least reveals the structure of the virus, which has been linked to microcephaly (though not yet definitively). The anatomy of the virus’s projections gives clues to how the virus is able to attach to and infect cells, and could provide toeholds for developing antiviral treatments and vaccines. Read coverage in the Washington Post and see the full paper in Science.

Meanwhile, as The New York Times reports, scientists are coming together in an effort to control Zika by genetically manipulating the mosquito that spreads it, Aedes aegypti.

Read Full Story | Leave a Comment

Consumerizing medicine: Are patient-initiated blood tests the future?

 

pink blood

The traditional model of health care has always been pretty linear: 1) observe your symptoms; 2) schedule a visit with your doctor; 3) meet with your doctor, answer questions, possibly have bloodwork or other testing; 4) follow your doctor’s advice.

But what if by the time you see the doctor, it’s too late to head off a serious medical problem? What if your doctor orders a blood test, but the closest lab is a 45-minute bus ride away, will charge a significant co-pay and closes at 5 p.m.?

The biomedical technology company Theranos has set out to upend this traditional model, simplifying the blood-testing process and giving individuals more control. The company’s goal is to establish wellness centers within five miles of every American, where anyone can order from a menu of blood tests with or without a doctor’s order. Walgreens already has 21 operating centers.

Read Full Story | Leave a Comment